Physician

David Cadwell Bartels, DO

According to 2025 Medicare claims, David Bartels, DO (NPI: 1245492768) practices hematology/oncology in the Coeur d'Alene, ID market, with the plurality of this provider's patient population coming from Kootenai, ID. This provider's primary affiliated billing organization is BEACON CANCER CARE PLLC (NPI: 1407335367; TIN: 83-1372781) and primary practice location at 83815-8434. Bartels is affiliated with the Kootenai Accountable Care, LLC (ACO ID: A3621) and Caravan Collaborative Pathways (ACO ID: A4604), participating under the MSSP model.

Bartels' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 753 traditional Medicare patients, billed 303,655 HCPCS/CPT codes, and received $7,444,516 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 1,231 prescription claims across 231 beneficiaries totaling $5,036,730 in drug costs, led by Tagrisso (Osimertinib Mesylate). DME data shows 73 claims. Open Payments data shows 101 records totaling $2,092. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $54,986 to $7,444,516. Similarly, Part D prescription costs have risen steadily, from $631,271 to $5,036,730. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $1,978 and ending at $2,330.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$3.7M$7.4M2015 Medicare payment: $54,986 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $798,797 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $2,733,436 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $2,641,505 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $6,088,517 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $7,405,837 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $6,609,407 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $6,757,153 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $6,086,449 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $7,444,516 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015269960$54,986
201635949,655$798,797
2017494144,538$2,733,436
2018525127,827$2,641,505
2019501250,908$6,088,517
2020541301,623$7,405,837
2021660275,855$6,609,407
2022675288,843$6,757,153
2023687263,833$6,086,449
2024753303,655$7,444,516

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$2.5M$5.0M2015 Drug cost: $631,271 (USD; Tot_Drug_Cst)2016 Drug cost: $757,756 (USD; Tot_Drug_Cst)2017 Drug cost: $265,849 (USD; Tot_Drug_Cst)2018 Drug cost: $1,996,358 (USD; Tot_Drug_Cst)2019 Drug cost: $3,197,066 (USD; Tot_Drug_Cst)2020 Drug cost: $3,207,309 (USD; Tot_Drug_Cst)2021 Drug cost: $2,767,804 (USD; Tot_Drug_Cst)2022 Drug cost: $3,384,685 (USD; Tot_Drug_Cst)2023 Drug cost: $1,430,632 (USD; Tot_Drug_Cst)2024 Drug cost: $5,036,730 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015115613$631,271
2016159763$757,756
2017142403$265,849
2018166646$1,996,358
2019170780$3,197,066
2020173747$3,207,309
2021156683$2,767,804
2022174766$3,384,685
2023159476$1,430,632
20242311,231$5,036,730

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$22K$43K2015 Medicare payment: $41,687 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $43,098 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $8,747 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $17,706 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $13,606 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $11,843 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $6,977 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $3,650 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $3,941 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $3,966 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
20151168$41,687
20161291$43,098
2017N/R44$8,747
201813121$17,706
201914140$13,606
202013158$11,843
2021N/R107$6,977
2022N/R84$3,650
2023N/R69$3,941
2024N/R73$3,966

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more211494$134
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more4651,469$93
80053Blood test, comprehensive group of blood chemicals3901,797$10
36415Insertion of needle into vein for collection of blood sample299826$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count4462,068$8

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
TagrissoOsimertinib Mesylate351,050$575,747
KisqaliRibociclib Succinate27700$365,257
RevlimidLenalidomide21560$315,811
LenalidomideLenalidomide30833$304,897
CalquenceAcalabrutinib Maleate21630$289,982

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
E1390Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rateYN/R19$1,605
J8700Temozolomide, oral, 5 mgNN/R16$1,184
J8521Capecitabine, oral, 500 mgNN/R12$688
Q0511Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day periodNN/R26$489

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.101$2,092PFIZER INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for David Cadwell Bartels, DO?

Tedicare shows public-source Medicare data for David Cadwell Bartels, DO (NPI 1245492768), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does David Cadwell Bartels, DO have ACO affiliation data?

David Cadwell Bartels, DO is shown with ACO affiliation data for Kootenai Accountable Care, LLC (MSSP, ACO ID A3621) and Caravan Collaborative Pathways (MSSP, ACO ID A4604).

What billing organization is linked to David Cadwell Bartels, DO?

David Cadwell Bartels, DO is linked to BEACON CANCER CARE PLLC (billing NPI 1407335367) in the available physician profile data.

Does David Cadwell Bartels, DO have Open Payments data?

David Cadwell Bartels, DO has 101 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.